Related Experiment Videos
Characterization of the F9 antigen(s) isolated from teratocarcinoma cell culture medium
Abstract:
Anti-F9 is a syngeneic antiserum directed against mouse teratocarcinoma cells which also reacts, by complement-mediated cytotoxicity, with early mouse embryos and male germ cells. A molecule (or molecules) which specifically inhibits anti-F9, cytotoxicity can be recovered from the culture medium of undifferentiated teratocarcinoma cells. The inhibitory component is not present in the culture medium of differentiated teratocarcinoma cells or embryonic fibroblasts. The inhibitory material binds to Ricinus communis I affinity columns indicating that it contains terminal non-reducing beta-galactosyl residues. The antigenicity of the molecule does not require protein, since the inhibitory activity is completely protease-resistant. Gel filtration indicates that the protease digested inhibitory material has a molecular weight of more than 80,000.
Insights
A molecule that inhibits anti-F9 cytotoxicity was found in undifferentiated teratocarcinoma cells. This protease-resistant molecule contains beta-galactosyl residues and is crucial for early development and germ cell research.
Area of Science:
- Developmental Biology
- Immunology
- Glycobiology
Background:
- Anti-F9 antiserum targets mouse teratocarcinoma cells, early embryos, and male germ cells via complement-mediated cytotoxicity.
- Teratocarcinoma cells offer a model for studying early developmental antigens.
Purpose of the Study:
- To identify and characterize molecules that inhibit anti-F9-mediated cytotoxicity.
- To investigate the biochemical properties and potential role of these inhibitory molecules in development.
Main Methods:
- Complement-mediated cytotoxicity assays using anti-F9 antiserum.
- Recovery and analysis of inhibitory substances from teratocarcinoma cell culture media.
- Affinity chromatography using Ricinus communis I.
- Protease resistance assays and gel filtration chromatography.
Main Results:
- A specific inhibitor of anti-F9 cytotoxicity was isolated from the culture medium of undifferentiated teratocarcinoma cells.
- The inhibitory component, absent in differentiated cells, contains terminal non-reducing beta-galactosyl residues.
- The inhibitory activity is protease-resistant and the digested material has a molecular weight >80,000 Da, suggesting a non-proteinaceous nature.
Conclusions:
- Undifferentiated teratocarcinoma cells secrete a molecule that protects against anti-F9 antibody-mediated cell lysis.
- This inhibitor, characterized by its beta-galactosyl residues and protease resistance, may play a role in regulating cell surface antigenicity during early development and germ cell formation.